Elaprase (Idursulfase Solution for Infusion) is distributed by Paladin Labs in Canada.
Product Information
Elaprase (Idursulfase) is an enzyme replacement therapy from Shire Human Genetic Therapies.Elaprase (Idursulfase) is designed to replace iduronate-2-sulfatase (I2S), the enzyme that is deficient or absent in people with Hunter syndrome.
Elaprase (Idursulfase) is a weekly infusion therapy, which means it is given intravenously (by IV).
Elaprase (Idursulfase) is designed to treat the underlying cause of Hunter syndrome by replacing the iduronate-2-sulfatase (I2S) enzyme which is deficient or absent in people with Hunter syndrome.
